Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Parkinsonism & Related Disorders

• Publication date

  2016-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.parkreldis.2016.02.008PMID 26898966
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reliability and factor structure of the Short Problem Behaviors Assessment for Huntington's disease (PBA-s) in the TRACK-HD and REGISTRY studies.

  2015cited by this paper
• Offspring of a parent with genetic disease: childhood experiences and adult psychological characteristics.

  2014cited by this paper
• Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY)

  2014cited by this paper
• The neuroanatomy of subthreshold depressive symptoms in Huntington's disease: a combined diffusion tensor imaging (DTI) and voxel-based morphometry (VBM) study

  2013cited by this paper
• Apathy in Parkinson's Disease: More Than Just Executive Dysfunction

  2013cited by this paper
• Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

  2013cited by this paper
• Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease.

  2012cited by this paper
• Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.

  2012cited by this paper
• Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.

  2011cited by this paper
• Huntington's disease: from molecular pathogenesis to clinical treatment

  2011cited by this paper
• Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY

  2010cited by this paper
• Cerebral cortex structure in prodromal Huntington disease.

  2010cited by this paper
• Correlates of apathy in Huntington's disease.

  2010cited by this paper
• Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.

  2009cited by this paper
• Behavioural problems in Huntington's disease using the Problem Behaviours Assessment.

  2008cited by this paper
• Huntington's disease

  2007cited by this paper
• The impact of Huntington's disease on family life.

  2007cited by this paper
• Huntington's disease.

  2007cited by this paper
• Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI.

  2007cited by this paper
• Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study.

  2007cited by this paper
• Specific psychiatric manifestations among preclinical Huntington disease mutation carriers.

  2007cited by this paper
• Psychopathology in verified Huntington's disease gene carriers.

  2007cited by this paper
• Apathy and the basal ganglia

  2006cited by this paper
• A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length

  2004cited by this paper
• Inhibition of subliminally primed responses is mediated by the caudate and thalamus: evidence from functional MRI and Huntington's disease.

  2003cited by this paper
• Neuropsychiatric assessment of Gilles de la Tourette patients: Comparative study with other hyperkinetic and hypokinetic movement disorders

  2001cited by this paper
• Behavioral changes in Huntington Disease.

  2001cited by this paper
• Rate of functional decline in Huntington’s disease

  2000cited by this paper
• Unified Huntington's disease rating scale: Reliability and consistency

  1996cited by this paper
• Functional decline in Huntington's disease

  1995cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper

• Decision context and neurobehavioural disturbance in Huntington’s disease

  2025cites this paper
• Consolidation deficits in episodic memory define distinct clinical and neurodegenerative profiles in Huntington’s disease

  2025cites this paper
• Depression reduces structurally informed network flexibility in premanifest Huntington’s disease

  2025cites this paper
• Update on Genetic Chorea

  2025cites this paper
• Mapping iron content and white matter integrity in the anterior thalamic radiations across Huntington’s disease stages

  2025cites this paper
• Natural products proposed for the management of Huntington’s disease (HD): a comprehensive review

  2025cites this paper
• Update on the Symptomatic Treatment of Huntington’s Disease: From Pathophysiology to Clinical Practice

  2025cites this paper
• Goal-directedness deficit in Huntington’s disease

  2025cites this paper
• Striato-cortical connectivity patterns predict clinical profiles in Huntington’s disease

  2025cites this paper
• A randomized clinical trial to evaluate the efficacy of cognitive rehabilitation and music therapy in mild cognitive impairment in Huntington’s disease

  2025cites this paper
• Mapping Longitudinal Psychiatric Signatures in Huntington's Disease.

  2025cites this paper
• The effect of Huntington’s disease on cognitive and physical motivation

  2024cites this paper
• Prodromal multiple sclerosis: considerations and future utility

  2024cites this paper
• Disrupted Time Perception Underlies Motivational Disturbances in Huntington’s Disease

  2024cites this paper
• Frequency of depression in Huntington's disease: A systematic review and meta-analysis

  2024cites this paper
• Cognitive engagement may slow clinical progression and brain atrophy in Huntington’s disease

  2024cites this paper
• Delineating the neural substrates of autobiographical memory impairment in Huntington's disease

  2024cites this paper
• Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient’s Perspective

  2024cites this paper
• Decision cost hypersensitivity underlies Huntington’s disease apathy

  2024cites this paper
• The meaning of apathy in Huntington's disease: A qualitative study of caregiver perspectives

  2024cites this paper
• Pathomechanisms of behavioral abnormalities in Huntington disease: an update

  2024cites this paper
• Associations of inflammatory cytokines and cortisol with nonmotor features of Huntington's disease

  2024cites this paper
• The pathobiology of depression in Huntington’s disease: an unresolved puzzle

  2024cites this paper
• Cognitive Impairment in Neurodegenerative Movement Disorders

  2023cites this paper
• Factors influencing cognitive function in patients with Huntington's disease from China: A cross‐sectional clinical study

  2023cites this paper
• The risk of criminal behavior in the elderly and patients with neurodegenerative disease.

  2023cites this paper
• Psychosis Caused by a Somatic Condition: How to Make the Diagnosis? A Systematic Literature Review

  2023cites this paper
• Measuring cognitive impairment and monitoring cognitive decline in Huntington’s disease: a comparison of assessment instruments

  2023cites this paper
• Neurophysiological correlates of non-motor symptoms in late premanifest and early-stage manifest huntington's disease.

  2023cites this paper
• Koro-like syndrome in Huntington's disease.

  2023cites this paper
• Understanding the Implications of a Complete Case Analysis for Regression Models with a Right-Censored Covariate

  2023cites this paper
• Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease

  2023cites this paper
• Mental health symptoms among those affected by Huntington's disease: A cross‐sectional study

  2023influential citation
• Self-Reported Social Relationship Capacities Predict Motor, Functional and Cognitive Decline in Huntington’s Disease

  2022cites this paper
• The Comprehensive Analysis of Motor and Neuropsychiatric Symptoms in Patients with Huntington’s Disease from China: A Cross-Sectional Study

  2022cites this paper
• A proof‐of‐concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's disease

  2022cites this paper
• Frequency and Pathophysiology of Apathy in Huntington Disease: A Systematic Review and Meta-Analysis.

  2022cites this paper
• Huntington’s disease phenocopy syndromes revisited: a clinical comparison and next-generation sequencing exploration

  2022cites this paper
• Apathy and Depression in Huntington's Disease: Distinct Longitudinal Trajectories and Clinical Correlates.

  2022cites this paper
• Medial prefrontal transcranial alternating current stimulation for apathy in Huntington's disease

  2022cites this paper
• Motivationally salient cue processing measured using the Monetary Incentive Delay (MID) task with electroencephalography (EEG): A potential marker of apathy in Huntingtons Disease

  2022cites this paper
• Investigating resting state neurophysiological markers of apathy and processing speed in prodromal and early-stage manifest Huntington's disease

  2022cites this paper
• Using a Clinical Formulation to Understand Psychological Distress in People Affected by Huntington’s Disease: A Descriptive, Evidence-Based Model

  2022cites this paper
• Temporal Characterization of Behavioral and Hippocampal Dysfunction in the YAC128 Mouse Model of Huntington’s Disease

  2022cites this paper
• Cognitive Syndromes Associated With Movement Disorders

  2022cites this paper
• Behavioral features in child and adolescent huntingtin gene‐mutation carriers

  2022cites this paper
• Disordered Decision Making: A Cognitive Framework for Apathy and Impulsivity in Huntington's Disease

  2022cites this paper
• Mindfulness-Based Stress Reduction in Pre-symptomatic Genetic Frontotemporal Dementia: A Pilot Study

  2022cites this paper
• A qualitative examination of apathy and physical activity in Huntington's and Parkinson's disease.

  2022cites this paper
• Enhanced Association of Tau Pathology and Cognitive Impairment in Mild Cognitive Impairment Subjects with Behavior Symptoms

  2022cites this paper
• Geographic Barriers Drive Disparities in Specialty Center Access for Older Adults with Huntington’s Disease

  2022cites this paper
• Plasma TDP-43 Reflects Cortical Neurodegeneration and Correlates with Neuropsychiatric Symptoms in Huntington’s Disease

  2022cites this paper
• Negative symptoms in Huntington’s disease

  2022cites this paper
• Psychometric Properties and Validation of the Polish Version of the 12-Item World Health Organization Disability Assessment Schedule 2.0 in Patients with Huntington’s Disease

  2021cites this paper
• Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease

  2021cites this paper
• Multidimensional Apathy: The Utility of the Dimensional Apathy Scale in Huntington's Disease

  2021cites this paper
• Gray Matter Vulnerabilities Predict Longitudinal Development of Apathy in Huntington's Disease

  2021cites this paper
• Psychosis in Huntington´s Disease. a rare and Under-Investigated Psychiatric Manifestation

  2021cites this paper
• Cognitive and behavioral associated changes in manifest Huntington disease: A retrospective cross‐sectional study

  2021cites this paper
• Clinical significance of self-descriptive apathy assessment in patients with neurological form of Wilson’s disease

  2021cites this paper
• The relationship between non-motor features and weight-loss in the premanifest stage of Huntington’s disease

  2021cites this paper
• The Maturing Minor

  2021cites this paper
• Olfactory Dysfunction in Huntington’s Disease

  2021cites this paper
• Interaction between sex and neurofilament light chain on brain structure and clinical severity in Huntington’s disease

  2021cites this paper
• Evaluation of Blood Glial Fibrillary Acidic Protein as a Potential Marker in Huntington's Disease

  2021cites this paper
• Another Perspective on Huntington’s Disease: Disease Burden in Family Members and Pre-Manifest HD When Compared to Genotype-Negative Participants from ENROLL-HD

  2021influential citation
• Cognitive and behavioral associated changes in manifest Huntington disease: A retrospective crossâ•’sectional study

  2021cites this paper
• Nosology and Phenomenology of Psychosis in Movement Disorders

  2020cites this paper
• The Therapeutic Potential of Neuronal K-Cl Co-Transporter KCC2 in Huntington’s Disease and Its Comorbidities

  2020cites this paper
• Cognitive decline heralds onset of symptomatic inherited prion disease

  2020cites this paper
• Apathy predicts rate of cognitive decline over 24 months in premanifest Huntington's disease

  2020cites this paper
• Antidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington’s disease (Enroll-HD)

  2020cites this paper
• Differential effects of SNARE-dependent gliotransmission on behavioral phenotypes in a mouse model of Huntington's disease.

  2020cites this paper
• The Impact of Anosognosia on Clinical and Patient-Reported Assessments of Psychiatric Symptoms in Huntington’s Disease

  2020cites this paper
• Irritability in Huntington’s Disease

  2020cites this paper
• The timing and impact of psychiatric, cognitive and motor manifestations of Huntington’s disease

  2020cites this paper
• Cortical and Striatal Circuits in Huntington’s Disease

  2020cites this paper
• How specific are non-motor symptoms in the prodrome of Parkinson's disease compared to other movement disorders?

  2020cites this paper
• Responsiveness to change over time and test-retest reliability of the PROMIS and Neuro-QoL mental health measures in persons with Huntington disease (HD)

  2020cites this paper
• Abnormal visual scanning and impaired mental state recognition in pre-manifest Huntington disease

  2020cites this paper
• Dissociable Motivational Deficits in Pre-manifest Huntington’s Disease

  2020cites this paper
• Structural brain correlates of irritability and aggression in early manifest Huntington’s disease

  2020cites this paper
• Autoscopic phenomena as an atypical psychiatric presentation of Huntington's disease: A case report including longitudinal clinical and neuroimaging data.

  2020cites this paper
• Cortical atrophic-hypometabolic dissociation in the transition from premanifest to early-stage Huntington’s disease

  2019cites this paper
• Mouvements anormaux et psychiatrie

  2019cites this paper
• Specific cognitive theory of mind and behavioral dysfunctions in early manifest Huntington disease: a case report

  2019influential citation
• The psychopharmacology of Huntington disease.

  2019cites this paper
• Impaired face-like object recognition in premanifest Huntington's disease.

  2019cites this paper
• Widespread Increased Diffusivity Reveals Early Cortical Degeneration in Huntington Disease

  2019cites this paper
• Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease

  2019cites this paper
• A Touchscreen Motivation Assessment Evaluated in Huntington's Disease Patients and R6/1 Model Mice

  2019cites this paper
• White matter cortico-striatal tracts predict apathy subtypes in Huntington's disease

  2019cites this paper
• Validity of irritability in Huntington's disease: A scoping review.

  2019cites this paper
• International Guidelines for the Treatment of Huntington's Disease

  2019cites this paper
• [Organic and psychiatric intricacy: The complex psychiatric disorder concept, paraclinical investigations].

  2019cites this paper
• Specific patterns of brain alterations underlie distinct clinical profiles in Huntington's disease

  2019cites this paper
• Early neurochemical modifications of monoaminergic systems in the R6/1 mouse model of Huntington's disease.

  2019cites this paper
• Positive Affect and Well-Being in Huntington’s Disease Moderates the Association Between Functional Impairment and HRQOL Outcomes

  2019cites this paper
• Apathy Is Related to Cognitive Control and Striatum Volumes in Prodromal Huntington’s Disease

  2019cites this paper
• Motivational Impairment is Accompanied by Corticoaccumbal Dysfunction in the BACHD-Tg5 Rat Model of Huntington's Disease.

  2019cites this paper